Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 31 n° 330

Posts Tagged ‘forex’

FXDD Announces Worldwide Launch of JForex Platform

Posted by fidest press agency su venerdì, 4 Mag 2012

New York, (PR Newswire) FXDD, a leader in online Forex trading and education, today announced the global availability of its JForex platform to clients worldwide. This platform, powered by Dukascopy Bank SA, allows traders to follow positions directly from charts and develop strategies based on multiple currency pairs.
(Logo: ) The platform is available in English and Spanish and additional languages will be made available in the near future.
Similar to FXDD’s JForex mobile app, the JForex platform lets traders efficiently manage orders while accessingstreaming quotes and advanced charting. The JForex platform features:
Live charts and technical analysis In-depth price information provided by high/low tables and pivot points Dow Jones FX Market News Dow Jones Economic Calendar Lowest FX spreads (starting from 0.5 pips) ECN liquidity (100-200 mio on majors) Instant order execution Access to trading reports Compatibility with MAC and PC One-click execution To get started with JForex, new FXDD clients can open a live or demo account online at: or
FXDD (, a Foreign Exchange Dealer registered with the CFTC and a member of the National Futures Association, is headquartered in New York City’s 7 World Trade Center. FXDD is a leader in online Forex trading dedicated to providing superior customer service, powerful trading technology, and reliable streaming liquidity. FXDD provides services to individual and institutional traders, hedge funds, commercial entities, brokerage firms and money managers around the world. FXDD offers 24-hour Forex trading by way of its trading platforms, which include: MetaTrader, PowerTrader, Mirror Trader, and FXDDTrader. The Company’s services currently provide competitive interbank pricing, no-interest accounts, and fully-automated execution. FXDD also provides 50:1 leverage in the US, as well as competitive bid-to-ask spreads. Follow FXDD and FXDD Europe on Twitter and on Facebook.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Forex Trading Tools: Trading From The Charts

Posted by fidest press agency su domenica, 4 marzo 2012

Saddle River, New Jersey, (PRNewswire)As one of the most widely traded markets in the world, forex trading tools are invaluable to a range of traders. As one of the largest and most liquid markets, the Foreign Exchange (often referred to as Forex or simply FX) is also one of the most accessible. Trading 24-hours a day from Sunday evening until Friday night with FX Solutions LLC; you can trade the opportunity as you see it.Whether you’re after short-term volatility or long-term price trend, you can trade FX based on international news or economic fundamentals.Whatever your trading style, it is imperative to have a platform from which you can both analyze and trade, potentially freeing up valuable time to focus on the market’s movements.
Arena Pharmaceuticals Files European Marketing Authorization Application for Lorcaserin for Weight Control
San Diego, (PRNewswire) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today the filing of a Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) for lorcaserin, an investigational drug candidate intended for weight control, including weight loss and maintenance of weight loss, in patients who are obese (BMI ≥ 30) or patients who are overweight (BMI ≥ 27) and have at least one weight-related co-morbid condition. Arena expects the EMA will accept the filing later this month and confirm the filing is sufficiently complete to permit a substantive review.
Lorcaserin is a new chemical entity that is believed to act as a selective serotonin 2C receptor agonist. The serotonin 2C receptor is expressed in the brain, including the hypothalamus, an area believed to be involved in the control of appetite and metabolism. Arena has patents that cover lorcaserin in the United States, major European countries and other jurisdictions that in most cases are capable of continuing into 2023 without taking into account any patent term extensions or other exclusivity Arena might obtain.
Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, an important class of validated drug targets, in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Posted in Estero/world news | Contrassegnato da tag: , , , | 2 Comments »